CanadaBis Capital Inc. (CANB.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.03 CAD | 636.36% |
| 2022 | 0.00 CAD | 122.22% |
| 2021 | -0.02 CAD | 54.06% |
| 2020 | -0.04 CAD | 54.29% |
| 2019 | -0.09 CAD | -445.09% |
| 2018 | -0.02 CAD | 27.62% |
| 2017 | -0.02 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.00 CAD | 0.0% |
| 2024 Q1 | 0.01 CAD | -43.33% |
| 2024 Q2 | 0.00 CAD | -84.31% |
| 2023 Q1 | 0.01 CAD | 45.71% |
| 2023 FY | - CAD | 636.36% |
| 2023 Q2 | 0.01 CAD | 84.31% |
| 2023 Q4 | 0.01 CAD | 3.45% |
| 2023 Q3 | 0.01 CAD | -7.45% |
| 2022 Q4 | 0.00 CAD | 288.89% |
| 2022 Q3 | 0.00 CAD | -55.0% |
| 2022 Q2 | 0.00 CAD | 200.0% |
| 2022 Q1 | -0.00 CAD | 77.27% |
| 2022 FY | - CAD | 122.22% |
| 2021 Q4 | -0.01 CAD | -450.0% |
| 2021 Q3 | -0.00 CAD | 60.98% |
| 2021 Q2 | -0.00 CAD | 33.87% |
| 2021 Q1 | -0.01 CAD | 0.0% |
| 2021 FY | - CAD | 54.06% |
| 2020 FY | - CAD | 54.29% |
| 2020 Q1 | -0.02 CAD | 0.0% |
| 2020 Q3 | -0.01 CAD | 37.39% |
| 2020 Q2 | -0.01 CAD | 42.5% |
| 2020 Q4 | - CAD | 100.0% |
| 2019 Q2 | -0.00 CAD | 55.56% |
| 2019 FY | - CAD | -445.09% |
| 2019 Q3 | -0.05 CAD | -5650.0% |
| 2019 Q1 | -0.00 CAD | 18.18% |
| 2019 Q4 | - CAD | 100.0% |
| 2018 FY | - CAD | 27.62% |
| 2018 Q3 | -0.00 CAD | 0.0% |
| 2018 Q4 | -0.00 CAD | 42.11% |
| 2018 Q1 | -0.00 CAD | 70.0% |
| 2017 Q4 | -0.00 CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -0.02 CAD | 244.643% |
| Decibel Cannabis Company Inc. | -0.00 CAD | 853.488% |
| Delivra Health Brands Inc. | 0.00 CAD | -945.161% |
| Entourage Health Corp. | -0.15 CAD | 121.6% |
| Lifeist Wellness Inc. | -0.58 CAD | 105.586% |
| Cannara Biotech Inc. | 0.08 CAD | 58.355% |
| Medicure Inc. | -0.09 CAD | 136.693% |
| PharmaCielo Ltd. | -0.10 CAD | 132.4% |
| Rubicon Organics Inc. | -0.03 CAD | 200.31% |
| BioSyent Inc. | 0.54 CAD | 94.0% |
| Voyageur Pharmaceuticals Ltd. | -0.01 CAD | 402.804% |